Relative susceptibilities to vancomycin and quinupristin-dalfopristin of adhered and planktonic vancomycin-resistant and vancomycin-susceptible coagulase-negative staphylococci

Current Microbiology

Volumn 48, Issue 3, 2004, Pages 214-218

  Halliman, Deanine G ^a,b   Ahearn, Donald G ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; SILICONE; SILVER; VANCOMYCIN; ANTIINFECTIVE AGENT; COAGULASE; QUINUPRISTIN-DALFOPRISTIN; SILICONE DERIVATIVE; VIRGINIAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; CELL WALL; CONTROLLED STUDY; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCACEAE; URINE CATHETER; ANTIBIOTIC RESISTANCE; CATHETERIZATION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCUS;

POSIBACTERIA; STAPHYLOCOCCI;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; CATHETERIZATION; COAGULASE; DRUG RESISTANCE, BACTERIAL; HYDROGELS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SILICONES; STAPHYLOCOCCUS; VANCOMYCIN; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 2942538590     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-003-4091-8     Document Type: Article

References (21)

1. Ahanotu EN, Stone JH, McAllister SK, Miller JM, Ahearn DG (2001) Vancomycin resistance among strains of Staphylococcus epidermidis: effects on adherence to silicone. Curr Microbiol 43:124-128
2. Ahearn DG, Grace DT, Jennings MJ, Borazjani RN, Boles KJ, Rose LJ, Simmons RB, Ahanotu EN (2000) Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 41:120-125
3. Berthaud N, Desnottes JF (1997) In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus. J Antimicrob Chemother 39, SupplA:99-102
4. Betriu C, Redondo M, Boloix A, Gómez, M, Culebras E, Picazo JJ (2001) Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother 48:911-913
5. Biavasco F, Vignaroli C, Varaldo PE (2000) Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 19:403-417
6. Biedenbach DJ, Ballow C, Schentag JJ, Jones RN (1999) Quinupristin/dalfopristin antimicrobial activity and spectrum in North America: report from 1998 isolates in the global smart study. J Antimicrob Chemother 44, SupplA:77
7. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 27:996-1006
8. Farber BF, Kaplan MH, Clogston AG (1990) Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 161:37-40
9. Gander S, Finch R (2000) The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of gram-positive bacteria. J Antimicrob Chemother 46:61-67
10. Hamilton-Miller JMT, Shah S (1997) Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J Antimicrob Chemother 39, SupplA:103-108
11. Miller MJ, Ahearn DG (1987) Adherence of Pseudomonas aeruginosa to hydrophilic contact lenses and other substrata. J Clin Microbiol 25:1392-1397
12. National Committee for Clinical Laboratory Standards (2003a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, 6th edition. M7-A6. Wayne, PA: NCCLS
13. National Committee for Clinical Laboratory Standards (2003b) Performance standards for antimicrobial disk susceptibility tests; Approved Standard, 8th edition. M2-A8. Wayne, PA: NCCLS
14. Nicas TI, Zeckel ML, Braun DK (1997) Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance. Trends Microbiol 5:240-249
15. Perlada DE, Smulian AG, Cushion MT (1997) Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J. Clin Microbiol 35:2342-2347
16. Pringle JH, Fletcher M (1986) Influence of substratum hydration and adsorbed macromolecules on bacterial attachment to surfaces. Appl Environ Microbiol 51:1321-1325
17. Raad I, Alrahwan A, Rolston K (1998) Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26:1182-1187
18. Ryffel C, Tesch W, Birch-Machin I, Reynolds PE, Barberis-Maino L, Kayser FH, Berger-Bächi B (1990) Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene 94:137-138
19. Schumacher-Perdreau F, Heilmann C, Peters G, Götz F, Pulverer G (1994) Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its adhesion-positive, accumulation-negative mutant M7. FEMS Microbiol Lett 117:71-78
20. von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677-685
21. Walsh TR, Howe RA (2002) The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 56:657-675